Nana Poku and Alexander Lyon

8h45 – 9h15 : State of the art hematopoietic stem-cell transplantation (HSCT) - A-C Mamez

9h15 - 9h45 : Cardiovascular manifestations during and after HSCT: T. Lopez Fernandez

9h45 – 10h15 : Keynote lecture : CART- cell, the past and the future – Thomas Pabst

10h15 – 10h30 : 1 Clinical case

10h30 – 10h45 : Coffee Break

10h45 – 11h15: TILS in solid tumors : experience from breast cancer – Anita Wolfer

11h15 – 11h45 : Challenges in non-bacterial thrombotic endocarditis in solid cancers and hematologic malignancies – Franck Thuny

11h45 – 12h30 : 3 clinical cases

12h30 – 13h30 : Lunch Break

13h30 - 14h : State of the art treatment of Lymphomas and sarcomas – Urban Novak

14h – 14h45 : “Keynote lecture: Mechanisms of cardiotoxicity - Douglas Sawyer

14h45 – 15h15 : Cardio-protection during high dose anthracycline therapy – Sol Andres

15h15 – 16h15 : Multimodality CV imaging during cancer therapy – State of the art CMR imaging (Chiara Bucciarelli-Ducci), echocardiography (Teresa Lopez Fernandez) and nuclear medicine imaging in cancer patients (Federico Caobelli). Moderator for the panel discussion Hajo Muller

16h15 – 16h30 : Coffee Break

16h30 – 17h : Targeted therapy with Tyrosine Kinase Inhibitors (TKI’s) and cardiac care during treatment – Sacha Rothschild and Alexander Lyon

17h – 17h20 : The management of dyslipidaemia in cancer patients - Sohaib Nazir

17h30 – 17h50 : Challenges in cancer survivorship programs – Eva Hägler Laube and Christina Schindera

17h50 – 18h30 : “Keynote lecture: Circulating Tumor DNA in Early- and Late-Stage Malignancies” – Naureen Starling

18h30 : Day’s highlights and closing remarks (François Mach)

19h : Guided Tour of Morat

20h : Networking Dinner

8h – 8h20 : State of the art management of Multiple myeloma and other light chain generating plasma cell dyscrasias – Carmen De Ramon Ortiz

8h20-8h40 : Cardiology care during and after multiple myeloma management – Stuart Rosen

8h45 – 9h30 : “Keynote lecture: AL cardiac amyloidosis” – Rodney Falk

9h30 – 10h : 2 Challenging clinical cases

10h – 10h15 : Coffee Break

10h15 – 11h: “Keynote lecture: ATTR cardiac amyloidosis” – Ronald M. Witteles

11h – 11h30: Genetic counselling and testing in cardiac amyloidosis – Siv Fokstuen

11h30 – 12h: 2 Challenging clinical cases

12h-13h: MEET THE EXPERTS – PANEL DISCUSSION (Rodney Falk, Ronald Witteles, Thomas Pabst, Carmen De Ramon Ortiz, Patrick Yerly). Amyloidosis survey results and discussion (Thomas Suter)

13h– 14h: Lunch Break

14h – 14h30: Lessons learned and reflections on the implementation the ESC 2022 cardio-oncology guidelines - Alexander Lyon and Thomas Suter)

14h30 – 15h: State of the art immune check point inhibitor therapy in solid tumours and cardiac care during therapy – Assma Ben Aissa and Gabriela Kuster Pfister

15h – 15h30: What’s new in breast cancer treatment and cardiac care during therapy – Evi Scheler

15h30 – 16h: Management of pre-existing cardiomyopathy and heart failure during anticancer therapy – Nana Poku

16h – 16h10: Presentation of the Swiss cardio-oncology group – Eva Hägler Laube

16h10 – 16h30: Coffee Break

16h30 – 17h: Structure of a cardio-oncology multidisciplinary team discussion – Sarah Hugelshofer and Bianca Giacomuzzi

17h – 17h30: The role of the GP and specialist nurse in cardio-oncology - Sivatharshini Ramalingam and Priya Reehal

17h30 – 18h: What is the ideal cardio-oncology education for the next generation – Thomas Suter

18h – 18h30: Research in cardio-oncology – Simon Kraler

18h30 – Final comments and conclusions - Nana Poku and Alexander Lyon